News & Perspective

Mar 01, 2018

Mar 01, 2018

News Scan for Mar 01, 2018

Low flu VE in Europe
Novavax flu vaccine trial
Avian flu outbreaks
Public health spending report card
Biodefense caucus forms

May 18, 2017

May 18, 2017

News Scan for May 18, 2017

Singapore Zika lessons
Novel H7N2 virulence
Clinical trial reporting standards

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Aug 20, 2010

Aug 20, 2010

Experts offer perspective on NDM-1 resistance threat

(CIDRAP News) – The recently reported factor that can make gram-negative bacteria resistant to nearly all antibiotics is a serious concern but does not necessarily top the list of resistance worries for healthcare in the United States, say two antimicrobial resistance experts who discussed the threat this week.

Jul 07, 2010

Jul 07, 2010

Non-vaccine aid for needy nations' pandemic response falls short

(CIDRAP News) – While donor countries and organizations have responded well to the need for pandemic flu vaccine for developing countries, the level of giving for other pandemic response efforts in needy countries so far has fallen short, the World Health Organization (WHO) said in a recent report.

Apr 21, 2009

Apr 21, 2009

States sound alarms over measles cases

(CIDRAP News) – Health officials in the Washington, DC, area today said they were working to identify people who may have been exposed to a patient with measles, as officials in other states, including Virginia, Iowa, and Pennsylvania, were responding to three other recent measles exposures.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»